🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SPH3127 tablet is a of renin inhibitor. It is expected to be a new drug for...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2019-01-11
Trial ID
NCT03756103
Treatments Being Tested
SPH3127-US-01 is a multi-center, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Clinical Research Associates, LLC
Start Date
2022-03-21
Trial ID
NCT05019742
To preliminarily evaluate the efficacy and safety of the renin inhibitor (S...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2023-03-22
Trial ID
NCT05593575
This study is a single-center, randomized, open, double-cycle and double-cr...
Status
Completed
Location
The capital medical university affiliated Beijing anzhen hospital
Start Date
2017-09-23
Trial ID
NCT03249753
Treatments Being Tested
To preliminarily evaluate the clinical efficacy of the renin inhibitor SPH3...
Status
Completed
Location
The First Affiliated Hospital，Sun Yat-sen University
Start Date
2023-06-19
Trial ID
NCT05770609
Treatments Being Tested
To quantitatively analyze the total radioactivity in the excreta of healthy...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2022-10-16
Trial ID
NCT05593562
Treatments Being Tested
The primary aim of the study is to assess the antihypertensive efficacy of ...
Status
Completed
Location
Beijing Hospital
Start Date
2021-06-10
Trial ID
NCT05359068
Treatments Being Tested
This study was a single center, parallel, randomized, double blind, placebo...
Status
Completed
Location
The capital medical university affiliated Beijing anzhen hospital
Start Date
2017-10-23
Trial ID
NCT03255993
Treatments Being Tested
1. To evaluate safety, tolerability and pharmacokinetics (PK) and pharmacod...
Status
Completed
Location
The capital medical university affiliated Beijing anzhen hospital
Start Date
2016-12-01
Trial ID
NCT03128138
Treatments Being Tested
A single center, open-label, fixed sequence Phase 1, drug-drug interaction ...
Status
Completed
Location
West China Second University Hospital, Sichuan University
Start Date
2021-12-13
Trial ID
NCT05359055
Treatments Being Tested